Purchases and Sales Made in Q2 2022 in Milestone Pharmaceuticals Inc. (MIST)
This table provides information about the institutional ownership of Milestone Pharmaceuticals Inc. (MIST) during Q2 2022. The information is specifically focused on institutions that hold shares of Milestone Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
500K+ 61.02% |
$2.56M - $3.68M
|
1.32M
$2.45M
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
500K+ 61.02% |
$2.56M - $3.68M
|
1.32M
$2.45M
|
|
|
Aug 15, 2022
Q2 2022
|
Lion Point Capital, LP
New York, NY |
BUY
|
- |
265K+ 38.77% |
$1.36M - $1.95M
|
949K
$1.76M
|
|
|
Aug 10, 2022
Q2 2022
|
Bleichroeder LP
New York, NY |
BUY
|
- |
263K+ 105.0% |
$1.35M - $1.93M
|
513K
$953K
|
|
|
Aug 15, 2022
Q2 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
77.2K+ 20.32% |
$396K - $569K
|
457K
$850K
|
|
|
Aug 15, 2022
Q2 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
69.4K+ 5.39% |
$356K - $512K
|
1.36M
$2.53M
|
|
|
Aug 12, 2022
Q2 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
13.6K+ 22.03% |
$69.8K - $100K
|
75.3K
$140K
|
|
|
Aug 15, 2022
Q2 2022
|
Lmr Partners LLP
London, X0 |
BUY
|
- |
11.7KNew |
$60.2K - $86.5K
|
11.7K
$21.8K
|
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
8.09K+ 79.74% |
$41.5K - $59.6K
|
18.2K
$33.9K
|
|
|
Jul 22, 2022
Q2 2022
|
Urban Wealth Management, LLC
|
BUY
|
- |
3.19KNew |
$16.4K - $23.5K
|
3.19K
$5.94K
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
1.02KNew |
$5.21K - $7.49K
|
1.02K
$1.89K
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-194- 0.89% |
$995 - $1.43K
|
21.6K
$40.2K
|
|
|
Aug 09, 2022
Q2 2022
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-5.55K- 28.82% |
$28.5K - $40.9K
|
13.7K
$25.5K
|
|
|
Aug 15, 2022
Q2 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-8K- 30.19% |
$41.1K - $59K
|
18.5K
$34.4K
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-10K- 73.94% |
$51.5K - $74K
|
3.54K
$6.58K
|
|
|
Aug 15, 2022
Q2 2022
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-10.2KClosed |
$52.1K - $74.9K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-15K- 6.62% |
$77K - $111K
|
212K
$394K
|
|
|
Aug 15, 2022
Q2 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-51.7K- 28.07% |
$265K - $381K
|
133K
$246K
|
|
|
Aug 12, 2022
Q2 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-549K- 28.48% |
$2.82M - $4.05M
|
1.38M
$2.57M
|
|
|
Aug 15, 2022
Q2 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-766K- 29.66% |
$3.93M - $5.65M
|
1.82M
$3.38M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.34M- 99.11% |
$6.88M - $9.88M
|
12K
$22.3K
|